8-KOther EventsExhibits & Filings

BECTON DICKINSON & CO 8-K Report, Corporate Update (Mar 13, 2015)

Filed March 13, 2015For Securities:BDX

Summary

Becton, Dickinson and Company (BD) filed a Form 8-K on March 13, 2015, to provide updated financial information related to changes in its reportable operating segments. Effective October 1, 2014, BD realigned its organizational structure into two primary business segments: BD Medical and BD Life Sciences. The BD Life Sciences segment now encompasses the former BD Diagnostics and BD Biosciences segments, reflecting a strategic shift to better align with its customer-focused solutions strategy. This filing does not introduce new events beyond the previously filed Form 10-K for the fiscal year ended September 30, 2014, but rather updates specific sections within that report (Item 7 and Item 8) to reflect the new segment reporting structure. Investors should note that comparative results under this new structure began to be reported with the Form 10-Q for the quarter ended December 31, 2014. This 8-K serves to provide clarity and updated disclosures regarding segment performance and resource allocation decisions.

Key Highlights

  • 1BD has reorganized its business into two primary segments: BD Medical and BD Life Sciences, effective October 1, 2014.
  • 2The BD Life Sciences segment now comprises the former BD Diagnostics and BD Biosciences businesses.
  • 3This organizational change is driven by a strategy to better complement the company's customer-focused solutions.
  • 4The filing provides updated financial information within the company's Form 10-K for the fiscal year ended September 30, 2014.
  • 5Specific updated sections include Management's Discussion and Analysis (Item 7) and Financial Statements (Item 8).
  • 6The company assesses segment performance and allocates resources based on operating income.
  • 7This 8-K filing does not reflect events occurring after the initial 10-K filing, other than the segment reporting update.

Frequently Asked Questions

The main purpose of this 8-K filing is to update financial information within Becton, Dickinson and Company's (BD) Annual Report on Form 10-K for the fiscal year ended September 30, 2014. Specifically, it reflects changes to BD's reportable operating segments implemented in fiscal year 2015.

Effective October 1, 2014, BD reorganized into two principal business segments: BD Medical and BD Life Sciences. The BD Life Sciences segment now combines the previously separate BD Diagnostics and BD Biosciences segments.

No, this filing does not provide new financial results for the fiscal year ended September 30, 2014. Instead, it updates specific sections of the previously filed Form 10-K to reflect the revised segment reporting structure that was put in place starting October 1, 2014. Comparative results under the new segment structure began appearing in the quarterly report for the period ended December 31, 2014.

BD evaluates the performance of its business segments and allocates resources to them primarily based on operating income.